Overview

IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients

Status:
Enrolling by invitation

Trial end date:
2021-12-31

Target enrollment:

Participant gender:

Summary

An open, single-center, randomized controlled phase II clinical trial to compare the efficacy and safety of conformal intensity modulated radiation therapy (IMRT) combined with carboplatin and IMRT combined with carboplatin and 5-FU in elderly patients with locally advanced esophageal squamous cell carcinoma at high risk of chemotherapy

Phase:

Phase 2

Details

Lead Sponsor:

Sun Yat-sen University

Treatments:

Carboplatin
Fluorouracil